Epitranscriptomic Enhancement of Influenza A Virus Gene Expression and Replication

Cell Host and Microbe

Volumn 22, Issue 3, 2017, Pages 377-386.e5

  Courtney, David G ^a   Kennedy, Edward M ^a   Dumm, Rebekah E ^a   Bogerd, Hal P ^a   Tsai, Kevin ^a   Heaton, Nicholas S ^a   Cullen, Bryan R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

epitranscriptomics; influenza A virus; m6A; mRNA function; post transcriptional regulation; RNA methylation; viral pathogenesis; YTHDF2

Indexed keywords

ADENOSINE; DNA; HEMAGGLUTININ; LENTIVIRUS VECTOR; MESSENGER RNA; RNA; SIALIDASE; RNA BINDING PROTEIN; TRANSCRIPTOME; VIRUS RNA; YTHDF2 PROTEIN, HUMAN; YTHDF2 PROTEIN, MOUSE;

A-549 CELL LINE; ARTICLE; BINDING AFFINITY; BINDING SITE; CLONAL CELL LINE; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; GENE PRODUCT; GENE REPLICATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; INFLUENZA A VIRUS; MOUSE; MUTAGENESIS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RNA VIRUS; TRANSCRIPTOMICS; VIRUS VIRULENCE; ANIMAL; C57BL MOUSE; DNA METHYLATION; FEMALE; GENETIC EPIGENESIS; GENETICS; HOST PATHOGEN INTERACTION; INFLUENZA; METABOLISM; METHYLATION; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; METHYLATION; MICE, INBRED C57BL; RNA, VIRAL; RNA-BINDING PROTEINS; TRANSCRIPTOME; VIRUS REPLICATION;

EID: 85030866081     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2017.08.004     Document Type: Article

References (39)

1. Bader, J.P., Brown, N.R., Chiang, P.K., Cantoni, G.L., 3-Deazaadenosine, an inhibitor of adenosylhomocysteine hydrolase, inhibits reproduction of Rous sarcoma virus and transformation of chick embryo cells. Virology 89 (1978), 494–505.
2. Batista, P.J., Molinie, B., Wang, J., Qu, K., Zhang, J., Li, L., Bouley, D.M., Lujan, E., Haddad, B., Daneshvar, K., et al. m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell 15 (2014), 707–719.
3. Boden, D., Pusch, O., Lee, F., Tucker, L., Ramratnam, B., Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 77 (2003), 11531–11535.
4. Bray, M., Driscoll, J., Huggins, J.W., Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor. Antivir. Res 45 (2000), 135–147.
5. Chen, K., Lu, Z., Wang, X., Fu, Y., Luo, G.Z., Liu, N., Han, D., Dominissini, D., Dai, Q., Pan, T., et al. High-resolution N(6) -methyladenosine (m(6) A) map using photo-crosslinking-assisted m(6) A sequencing. Angew. Chem. Int. Ed. 54 (2015), 1587–1590.
6. Das, A.T., Brummelkamp, T.R., Westerhout, E.M., Vink, M., Madiredjo, M., Bernards, R., Berkhout, B., Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol. 78 (2004), 2601–2605.
7. Desrosiers, R.C., Friderici, K.H., Rottman, F.M., Characterization of Novikoff hepatoma mRNA methylation and heterogeneity in the methylated 5’ terminus. Biochemistry 14 (1975), 4367–4374.
8. Durbin, A.F., Wang, C., Marcotrigiano, J., Gehrke, L., RNAs containing modified nucleotides fail to trigger RIG-I conformational changes for innate immune signaling. MBio, 7, 2016 e00833–16.
9. Fischer, A.A., Muller, K., Scholtissek, C., Specific inhibition of the synthesis of influenza virus late proteins and stimulation of early, M2, and NS2 protein synthesis by 3-deazaadenosine. Virology 177 (1990), 523–531.
10. Fry, N.J., Law, B.A., Ilkayeva, O.R., Holley, C.L., Mansfield, K.D., N6-Methyladenosine is required for the hypoxic stabilization of specific mRNAs. RNA, 2017, 10.1261/rna.061044.117.
11. Fustin, J.M., Doi, M., Yamaguchi, Y., Hida, H., Nishimura, S., Yoshida, M., Isagawa, T., Morioka, M.S., Kakeya, H., Manabe, I., et al. RNA-methylation-dependent RNA processing controls the speed of the circadian clock. Cell 155 (2013), 793–806.
12. Geula, S., Moshitch-Moshkovitz, S., Dominissini, D., Mansour, A.A., Kol, N., Salmon-Divon, M., Hershkovitz, V., Peer, E., Mor, N., Manor, Y.S., et al. Stem cells. m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation. Science 347 (2015), 1002–1006.
13. Gokhale, N.S., McIntyre, A.B., McFadden, M.J., Roder, A.E., Kennedy, E.M., Gandara, J.A., Hopcraft, S.E., Quicke, K.M., Vazquez, C., Willer, J., et al. N6-methyladenosine in Flaviviridae viral RNA genomes regulates infection. Cell Host Microbe 20 (2016), 654–665.
14. Gonzales-van Horn, S.R., Sarnow, P., Making the mark: the role of adenosine modifications in the life cycle of RNA viruses. Cell Host Microbe 21 (2017), 661–669.
15. Hafner, M., Landthaler, M., Burger, L., Khorshid, M., Hausser, J., Berninger, P., Rothballer, A., Ascano, M. Jr., Jungkamp, A.C., Munschauer, M., et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141 (2010), 129–141.
16. Heaton, N.S., Moshkina, N., Fenouil, R., Gardner, T.J., Aguirre, S., Shah, P.S., Zhao, N., Manganaro, L., Hultquist, J.F., Noel, J., et al. Targeting viral proteostasis limits influenza virus, HIV, and dengue virus infection. Immunity 44 (2016), 46–58.
17. Hongay, C.F., Orr-Weaver, T.L., Drosophila inducer of MEiosis 4 (IME4) is required for Notch signaling during oogenesis. Proc. Natl. Acad. Sci. USA 108 (2011), 14855–14860.
18. Houser, K., Subbarao, K., Influenza vaccines: challenges and solutions. Cell Host Microbe 17 (2015), 295–300.
19. Kariko, K., Buckstein, M., Ni, H., Weissman, D., Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23 (2005), 165–175.
20. Kawakami, E., Watanabe, T., Fujii, K., Goto, H., Watanabe, S., Noda, T., Kawaoka, Y., Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J. Virol. Methods 173 (2011), 1–6.
21. Ke, S., Pandya-Jones, A., Saito, Y., Fak, J.J., Vagbo, C.B., Geula, S., Hanna, J.H., Black, D.L., Darnell, J.E. Jr., Darnell, R.B., m6A mRNA modifications are deposited in nascent pre-mRNA and are not required for splicing but do specify cytoplasmic turnover. Genes Dev. 31 (2017), 990–1006.
22. Kennedy, E.M., Bogerd, H.P., Kornepati, A.V., Kang, D., Ghoshal, D., Marshall, J.B., Poling, B.C., Tsai, K., Gokhale, N.S., Horner, S.M., et al. Posttranscriptional m(6)A editing of HIV-1 mRNAs enhances viral gene expression. Cell Host Microbe 19 (2016), 675–685.
23. Kennedy, E.M., Courtney, D.G., Tsai, K., Cullen, B.R., Viral epitranscriptomics. J. Virol., 91, 2017 e02263–16.
24. Konermann, S., Brigham, M.D., Trevino, A.E., Joung, J., Abudayyeh, O.O., Barcena, C., Hsu, P.D., Habib, N., Gootenberg, J.S., Nishimasu, H., et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517 (2015), 583–588.
25. Krug, R.M., Morgan, M.A., Shatkin, A.J., Influenza viral mRNA contains internal N6-methyladenosine and 5’-terminal 7-methylguanosine in cap structures. J. Virol. 20 (1976), 45–53.
26. Langmead, B., Trapnell, C., Pop, M., Salzberg, S.L., Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol., 10, 2009, R25.
27. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., Genome Project Data Processing, S., The sequence alignment/map format and SAMtools. Bioinformatics 25 (2009), 2078–2079.
28. Li, S., Mason, C.E., The pivotal regulatory landscape of RNA modifications. Annu. Rev. Genomics Hum. Genet. 15 (2014), 127–150.
29. Lichinchi, G., Gao, S., Saletore, Y., Gonzalez, G.M., Bansal, V., Wang, Y., Mason, C.E., Rana, T.M., Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells. Nat. Microbiol., 1, 2016, 16011.
30. Lichinchi, G., Zhao, B.S., Wu, Y., Lu, Z., Qin, Y., He, C., Rana, T.M., Dynamics of human and viral RNA methylation during Zika virus infection. Cell Host Microbe 20 (2016), 666–673.
31. Linder, B., Grozhik, A.V., Olarerin-George, A.O., Meydan, C., Mason, C.E., Jaffrey, S.R., Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat. Methods 12 (2015), 767–772.
32. Meyer, K.D., Jaffrey, S.R., The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat. Rev. Mol. Cell Biol. 15 (2014), 313–326.
33. Narayan, P., Ayers, D.F., Rottman, F.M., Maroney, P.A., Nilsen, T.W., Unequal distribution of N6-methyladenosine in influenza virus mRNAs. Mol. Cell Biol 7 (1987), 1572–1575.
34. Quinlivan, M., Zamarin, D., Garcia-Sastre, A., Cullinane, A., Chambers, T., Palese, P., Attenuation of equine influenza viruses through truncations of the NS1 protein. J. Virol. 79 (2005), 8431–8439.
35. Sanjana, N.E., Shalem, O., Zhang, F., Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11 (2014), 783–784.
36. Tirumuru, N., Zhao, B.S., Lu, W., Lu, Z., He, C., Wu, L., N(6)-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 Gag protein expression. Elife, 5, 2016, 10.7554/eLife.15528.001.
37. Wang, X., Lu, Z., Gomez, A., Hon, G.C., Yue, Y., Han, D., Fu, Y., Parisien, M., Dai, Q., Jia, G., et al. N6-Methyladenosine-dependent regulation of messenger RNA stability. Nature 505 (2014), 117–120.
38. Wyde, P.R., Ambrose, M.W., Meyer, H.L., Zolinski, C.L., Gilbert, B.E., Evaluation of the toxicity and antiviral activity of carbocyclic 3-deazaadenosine against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats. Antivir. Res 14 (1990), 215–225.
39. Zhong, S., Li, H., Bodi, Z., Button, J., Vespa, L., Herzog, M., Fray, R.G., MTA is an Arabidopsis messenger RNA adenosine methylase and interacts with a homolog of a sex-specific splicing factor. Plant Cell 20 (2008), 1278–1288.